CONGRESS COVERAGE: ASCO 2021 – FOCUS ON GI
Expert perspectives and strategic insights on the latest therapeutic developments in GI cancer treatment from the ASCO GI 2021 congress, and implications on individualized clinical decision-making.
FACULTY MEMBERS
Dirk Arnold, MD, PhD
University of Hamburg and Asklepios Tumor Center
Hamburg, Germany
Scott Kopetz, MD, PhD
MD Anderson Cancer Center
Houston, TX, USA
Fotios Loupakis, MD, PhD
Veneto Institute of Oncology
Padua, Italy
Tanios S. Bekaii-Saab, MD
Mayo Clinic
Phoenix, AZ, USA
Cathy Eng, MD, FACP
Vanderbilt University Medical Center
Nashville, TN, USA
David Ilson, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY, USA
Eric Van Cutsem, MD, PhD
University of Leuven
Leuven, Belgium
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
The report that will be produced on the basis of the meeting will discuss the following topics
- Colorectal Cancer – Chemotherapy and Targeted Therapy
- Colorectal Cancer – Immunotherapy
- Hepatocellular Carcinoma
- Gastroesophageal Cancers
- Pancreatic Cancer
